Connectus Wealth, LLC Biomarin Pharmaceutical Inc Transaction History
Connectus Wealth, LLC
- $4.37 Billion
- Q1 2024
A detailed history of Connectus Wealth, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Connectus Wealth, LLC holds 3,011 shares of BMRN stock, worth $185,869. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,011
Previous 3,011
-0.0%
Holding current value
$185,869
Previous $290,000
9.66%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding BMRN
# of Institutions
641Shares Held
178MCall Options Held
2MPut Options Held
1.28M-
Black Rock Inc. New York, NY22.7MShares$1.4 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.3MShares$1.19 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.9MShares$1.16 Billion0.99% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$858 Million0.59% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.5MShares$648 Million0.16% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $11.5B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...